<DOC>
	<DOC>NCT00852696</DOC>
	<brief_summary>The purpose of this study is to determine whether treatment with anti-muscarinic medications following sub-urethral sling procedures improves overall subjective and objective outcomes in women with mixed incontinence with primary stress symptoms.</brief_summary>
	<brief_title>Over Active Bladder Patients Having Sling Surgery</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<criteria>Age &gt;/= 18 Patient is appropriate for suburethral sling procedure Mixed urinary incontinence No antimuscarinic therapy for previous 30 days Uncontrolled narrow angle glaucoma Acute cystitis Unevaluated hematuria Currently using antimuscarinic therapy Unable to complete preoperative urodynamics Contraindication to anticholinergic therapy Unable or unwilling to complete diaries or quality of life questionaire Significant (exteriorized) Pelvic Organ Prolapse</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Overactive Bladder</keyword>
	<keyword>Incontinence</keyword>
	<keyword>Solifenacin</keyword>
	<keyword>Women</keyword>
	<keyword>Postoperative</keyword>
</DOC>